View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
April 23, 2021

Twitter round-up: Eric Topol’s tweet on Covid-19 being transmitted through the air most popular tweet in Q1 2021

Pharmaceutical Technology lists five of the most popular tweets on Covid-19 pharma in Q1 2021 based on data from GlobalData’s Influencer Platform.

By GlobalData Healthcare

The top tweets were chosen from influencers as tracked by GlobalData’s Influencer Platform, which is based on a scientific process that works on pre-defined parameters. Influencers are selected after a deep analysis of the influencer’s relevance, network strength, engagement, and leading discussions on new and emerging trends.

Top tweets on Covid-19 pharma in Q1 2021

1. Eric Topol’s tweet on Covid-19 being transmitted through the air

Eric Topol, a cardiologist and founder and director of the Scripps Research Translational Institute, shared an article about the SARS-CoV-2 being transmitted mainly through the air in the form of tiny particles or droplets called aerosols that are released when people breathe or talk.

The World Health Organisation (WHO) and US Centres for Disease Control and Prevention (CDC), however, have emphasised that despite limited evidence of the Covid-19 being transmitted through contaminated surface or fomites, it is possible, given the rise in infections as a result of close vicinity to those infected. Therefore, frequently disinfecting objects and surfaces is important, the article noted.

Username: Eric Topol

Twitter handle: @EricTopol

Retweets: 4,535

Likes: 8,347

2. Laurie Garrett’s tweet on Pfizer vaccine’s high efficacy rate in Israel

Laurie Garrett, a science journalist and author, shared an article on Israel having vaccinated most of its population with the Pfizer-BioNTech Covid-19 vaccine. The Maccabi health fund released preliminary results of a study that compared vaccinated and not vaccinated individuals’ possibility to get infected with the SARS-CoV-2 virus and found the vaccine to be 92% effective when taken in two complete doses. In other words, just 0.04% of the Israeli’s got infected after taking the second shot. However, one dose was found to offer poor protection, with only 30% effective in senior patients.

More than three million Israelis have been administered with the first dose of the Pfizer vaccine, which includes 82% of the population aged above 60 years, while 1.5 million have received both the jabs. The country started inoculating its younger population in January 2021, administering 200,000 shots per day to individuals as young as 35 years.

Username: Laurie Garrett

Twitter handle: @Laurie_Garrett

Retweets: 804

Likes: 2,813

3. Francis S. Collins’ tweet on long Covid

Francis S. Collins, director of the National Institutes of Health (NIH), medical research agency, shared an article on the Covid-19 disease leaving lingering and weakening symptoms in individuals, commonly referred to as long Covid. The NIH is conducting a study to identify the reasons behind long Covid and ways to prevent as well as treat it.

The symptoms of long Covid range from fatigue, brain fog, shortness of breath, gastrointestinal issues, and also psychological problems such as anxiety and depression. The new symptoms manifest in some individuals after getting infected or over a period of time. NIH has also received a funding of $1.15bn in December 2020, to examine the prolonged health complications occurring due to SARS-CoV-2 infection.

Username: Francis S. Collins

Twitter handle: @NIHDirector

Retweets: 735

Likes: 1,854

4. Atul Gupta’s tweet on Pfizer-BioNTech Covid-19 vaccine being effective against new variants

Atul Gupta, chief medical officer at Philips Image Guided Therapy, a company providing solutions for minimally invasive procedures, shared an article on the Pfizer-BioNTech Covid-19 vaccine being effective against not just the new UK and South African Covid-19 variants but against 14 other mutations. The vaccine is able to protect against mutations found in the latest variants discovered in South Africa and the UK, which have a high rate of transmissibility.

A study conducted by scientists from the University of Texas Medica Branch found the vaccine to be effective in neutralising variants with the N501Y mutation, located on the virus that it uses to enter and infect the cells. Scientists claim that the N501Y mutation is highly transmissible, while mutations found in the UK and South African variants could potentially change the functions of the virus, the article detailed.

Username: Atul Gupta

Twitter handle: @AtulGupta_MD

Retweets: 603

Likes: 1,663

5. Richard Urso’s tweet on common asthma drug reducing Covid-19 hospitalisations

Richard Urso, an ophthalmologist, shared an article on a common asthma drug reducing Covid-19 hospitalisation risk by 90% and recovery time. A research team at the Oxford University revealed that budesonide, a drug used to treat smokers’ lungs, diminishes the risk of emergency care or hospitalisation among Covid-19 patients, if administered within the first seven days of symptoms.

Initial data found volunteers treated with budesonide to respond more quickly to fever and other symptoms. Researchers claim the trial was conducted because fewer number of patients with chronic respiratory diseases, who are often on inhaled steroids, were admitted at hospitals during the early days of the pandemic.

Username: Richard Urso

Twitter handle: @richardursomd

Retweets: 1,007

Likes: 1,565

 

Related Companies

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU